We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+20.24%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$160M
AUM Growth
-$12.7M
Cap. Flow
-$14.4M
Cap. Flow %
-9.01%
Top 10 Hldgs %
73.06%
Holding
57
New
11
Increased
13
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
TENX icon
Tenax Therapeutics
TENX
+$6.76M
2
IMMX icon
Immix Biopharma
IMMX
+$5.18M
3
AVR
Anteris Technologies
AVR
+$4.02M
4
STRO icon
Sutro Biopharma
STRO
+$3.62M
5
XNCR icon
Xencor
XNCR
+$3.1M

Top Sells

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.9M
2
LNTH icon
Lantheus
LNTH
+$4.97M
3
MLYS icon
Mineralys Therapeutics
MLYS
+$4.11M
4
RAPT
RAPT Therapeutics
RAPT
+$3.66M
5
TERN
Terns Pharmaceuticals
TERN
+$2.83M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNTH icon
51
Lantheus
LNTH
$6.51B
– –
-74,687
Closed -$4.97M
PYXS icon
52
Pyxis Oncology
PYXS
$185M
– –
-40,000
Closed -$46K
RAPT
53
DELISTED
RAPT Therapeutics
RAPT
– –
-108,000
Closed -$3.66M
TERN
54
DELISTED
Terns Pharmaceuticals
TERN
– –
-70,000
Closed -$2.83M
TRVI icon
55
CALL
Trevi Therapeutics
TRVI
$2.57B
– –
-38,500
Closed -$482K
TRVI icon
56
Trevi Therapeutics
TRVI
$2.57B
– –
-205,000
Closed -$2.57M
VTYX
57
DELISTED
Ventyx Biosciences
VTYX
– –
-40,000
Closed -$361K
1 2
3

Similar funds

CSA
Cornerstone Select Advisors St. Louis, Missouri $160M AUM 46.79% 1-Year Est. Return
BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
RFS
Richardson Financial Services Medway, Massachusetts $160M AUM 16.71% 1-Year Est. Return
AIA
Affinity Investment Advisors Newport Beach, California $160M AUM 42.7% 1-Year Est. Return
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
WHCI
W.H. Cornerstone Investments Kingston, Massachusetts $160M AUM 13.88% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM

Velan Capital Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Velan Capital Investment Management held 57 positions worth $160M, down 7.4% from $172M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Velan Capital Investment Management withdrew a net $14.4M in Q1 2026, closing 8 positions and reducing 7 holdings. Its most notable exit was Cidara Therapeutics, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

Against the trend, Velan Capital Investment Management opened a new position in Anteris Technologies worth $3.88M.

  • Velan Capital Investment Management's largest Q1 2026 buy was Anteris Technologies: 700,000 shares worth $3.88M.
  • Velan Capital Investment Management added most to Tenax Therapeutics in Q1 2026, an estimated $6.76M increase.
  • Velan Capital Investment Management's biggest Q1 2026 reduction was Mineralys Therapeutics, cutting an estimated $4.11M.
  • Velan Capital Investment Management fully exited Cidara Therapeutics in Q1 2026, selling an estimated $23.9M.
  • Velan Capital Investment Management's ten largest holdings make up 73% of its $160M portfolio in Q1 2026.
  • Velan Capital Investment Management opened 11 new positions and closed 8 in Q1 2026.
  • Velan Capital Investment Management's portfolio value fell 7.4% quarter-over-quarter to $160M.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.